Atossa Therapeutics Q3 EPS $(0.56) Beats $(0.90) Estimate
Benzinga Newsdesk 4 hours ago
NewsEarningsEarnings Beats
Atossa Therapeutics (NASDAQ:ATOS) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.90) by 37.08 percent. This is a 60 percent decrease over losses of $(0.35) per share from
Atossa Therapeutics (NASDAQ:ATOS) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.90) by 37.08 percent. This is a 60 percent decrease over losses of $(0.35) per share from the same period last year.